Quercetin ingestion does not alter cytokine changes in athletes competing in the Western States endurance run

Journal of Interferon and Cytokine Research

Volumn 27, Issue 12, 2007, Pages 1003-1011

  Nieman, David C ^a   Henson, Dru A ^a   Davis, J Mark ^a,b   Dumke, Charles L ^a   Gross, Sarah J ^a   Jenkins, D Paul ^a   Murphy, E Angela ^a,b   Carmichael, Martin D ^a,b   Quindry, John C ^a   McAnulty, Steven R ^a   McAnulty, Lisa S ^a   Utter, Alan C ^a   Mayer, Eugene P ^a,b  

^a APPALACHIAN STATE UNIVERSITY   (United States)

^b UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CYTOKINE; HYDROCORTISONE; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 6; INTERLEUKIN 8; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; PLACEBO; PROLYLLEUCYLGLYCINAMIDE; QUERCETIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BLOOD SAMPLING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG MECHANISM; ENDURANCE; FEMALE; HORMONE BLOOD LEVEL; HUMAN; INFLAMMATION; MALE; MARATHON RUNNER; MUSCLE INJURY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RUNNING; STATISTICAL SIGNIFICANCE;

ADULT; CYTOKINES; DOUBLE-BLIND METHOD; FEMALE; HUMANS; LEUKOCYTES; MALE; MIDDLE AGED; PHYSICAL ENDURANCE; QUERCETIN; RNA, MESSENGER; RUNNING;

ELAGATIS;

EID: 38049035487     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/jir.2007.0050     Document Type: Article

References (38)

1. Suzuki K, Totsuka M, Nakaji S, Yamada M, Kudoh S, Liu Q, Sugawara K, Yamaya K, Sato K. Endurance exercise causes interaction among stress hormones, cytokines, neutrophil dynamics, and muscle damage. J. Appl. Physiol. 1999;87:1360-1367.
2. Nieman DC, Henson DA, McAnulty SR, McAnulty LS, Morrow JD, Ahmed A, Heward CB. Vitamin E and immunity after the Kona Triathlon World Championship. Med. Sci. Sports Exerc. 2004;36:1328-1335.
3. Nieman DC, Dumke CL, Henson DA, McAnulty SR, Gross SJ, Lind RH. Muscle damage is linked to cytokine changes following a 160-km race. Brain Behav. Immun. 2005;19:398-403.
4. Nieman DC, Oley K, Henson DA, Dumke CL, McAnulty SR, Davis JM, Murphy EA, Lind RH. Ibuprofen use, endotoxemia, inflammation, and plasma cytokines during ultramarathon competition. Brain Behav. Immun. 2006;20:578-584.
5. Nieman DC, Dumke CL, Henson DA, McAnulty SR, McAnulty LS, Lind RH, Morrow JD. Immune and oxidative changes during and following the Western States Endurance Run. Int. J. Sports Med. 2003;24:541-547.
6. Nieman DC, Davis JM, Henson DA, Walberg-Rankin J, Shute M, Dumke CL, Utter AC, Vinci DM, Carson J, Brown A, Lee WJ, McAnulty SR, McAnulty LS. Carbohydrate ingestion influences skeletal muscle cytokine mRNA and plasma cytokine levels after a 3-h run. J. Appl. Physiol. 2003;94:1917-1925.
7. Nieman DC, Davis JM, Henson DA, Gross SJ, Dumke CL, Utter AC, Vinci DM, Carson JA, Brown A, McAnulty SR, McAnulty LS, Triplett NT. Skeletal muscle cytokine mRNA and plasma cytokine changes after 2.5-h cycling: influence of carbohydrate. Med. Sci. Sports Exerc. 2005;37:1283-1290.
8. Nieman DC, Henson DA, Davis JM, Dumke CL, Utter AC, Murphy EA, Pearce S, Gojanovich G, McAnulty SR, McAnulty LS. Blood leukocyte mRNA expression for IL-10, IL-1ra, and IL-8, but not IL-6, increases after exercise. J. Interferon Cytokine Res. 2006;26:668-674.
9. Steensberg A, Keller C, Hillig T, Fr sig C, Wojtaszewski JFP, Pedersen BK, Pilegaard H, Sander M. Nitric oxide production is a proximal signaling event controlling exercise-induced mRNA expression in human skeletal muscle. FASEB J. 2007;21:2683-2694.
10. Erdman JW, Balentine D, Arab L, Beecher G, Dwyer JT, Folts J, Harnly J, Hollman P, Keen CL, Mazza G, Messina M, Scalbert A, Vita J, Williamson G, Burrowes J. Flavonoids and heart health: Proceedings of the ILSI North America Flavonoids Workshop, May 31-June 1, 2005, Washington, DC. J. Nutr. 2007;137:718S-737S.
11. Manach C, Scalbert A, Morand C, Rémésy C, Jiménez L. Polyphenols: food sources and bioavailability. Am. J. Clin. Nutr. 2004;79:727-747.
12. Manach C, Williamson G, Morand C, Scalbert A, Rémésy C. Bioavailability and bioefficiency of polyphenols in humans. 1. Review of 97 bioavailability studies. Am. J. Clin. Nutr. 2005;81(Suppl):230S-242S.
13. Walle T, Walle UK, Halushka PV. Carbon dioxide is the major metabolite of quercetin in humans. J. Nutr. 2001;131:2648-2652.
14. De Boer VCJ, Dihal AA, van der Woude H, Arts ICW, Wolffram S, Alink GM, Rietjens IMCM, Keijer J, Hollman PEH. Tissue distribution of quercetin in rats and pigs. J. Nutr. 2005;135:1718-1725.
15. Okamoto T. Safety of quercetin for clinical application. Int. J. Mol. Med. 2005;16:275-278.
16. Theodoratou E, Kyle J, Cetnarskyj R, Farrington SM, Tenesa A, Barnetson R, Porteous M, Dunlop M, Campbell H. Dietary flavonoids and the risk of colorectal cancer. Cancer Epidemiol. Biomarkers Prev. 2007;16:684-693.
17. McCann SE, Ambrosone CB, Moysich KB, Brasure J, Marshall JR, Freudenheim JL, Wilkinson GS, Graham S. Intakes of selected nutrients, foods, and phytochemicals and prostate cancer risk in western New York. Nutr. Cancer 2005;53:33-41.
18. Neuhouser ML. Dietary flavonoids and cancer risk: evidence from human population studies. Nutr. Cancer 2004;50:1-7.
19. Knekt P, Kumpulainen J, JÑrvinen R, Rissanen H, Heliîvaara M, Reunanen A, Hakulinen T, Aromaa A. Flavonoid intake and risk of chronic diseases. Am. J. Clin. Nutr. 2002;76:560-568.
20. Nair MP, Mahajan S, Reynolds JL, Aalinkeel R, Nair H, Schwartz SA, Kandaswami C. The flavonoid quercetin inhibits proinflammatory cytokine (tumor necrosis factor alpha) gene expression in normal peripheral blood mononuclear cells via modulation of the NF-κB system. Clin. Vaccine Immunol. 2006;13:319-328.
21. Comalada M, Ballester I, Bailón E, Sierra S, Xaus J, Gálvez J, de Medina FS, Zarzuelo A. Inhibition of pro-inflammatory markers in primary bone marrow-derived mouse macrophages by naturally occurring flavonoids: analysis of the structure-activity relationship. Biochem. Pharmacol. 2006;72:1010-1021.
22. Chen JC, Ho FM, Chao PDL, Chen CP, Jeng KCG, Hsu HB, Lee ST, Wu WT, Lin WW. Inhibition of iNOS gene expression by quercetin is mediated by the inhibition of IκB kinase, nuclear factor-kappa B and Stat1, and depends on heme oxygenase-1 induction in mouse BV-2 microglia. Eur. J. Pharmacol. 2005;521:9-20.
23. Martínez-Flórez S, Gutiérrez-Fernández B, Sánchez-Campos S, González-Gallego J, Tunón MJ. Quercetin attenuates nuclear factor-κB activation and nitric oxide production in interluekin-1β-activated rat hepatocytes. J. Nutr. 2005;135:1359-1365.
24. Nam NH. Naturally occurring NFκB inhibitors. Mini Rev. Med. Chem. 2006;6:945-951.
25. Dias AS, Porawski M, Alonso M, Marroni N, Collado PS, González-Gallego J. Quercetin decreases oxidative stress, NFκB activation, and iNOS overexpression in liver of streptozotocin-induced diabetic rats. J. Nutr. 2005;135:2299-2304.
26. Ciz M, Pavelkova M, Gallova L, Kralova J, Kubala L, Lojek A. The influence of wine polyphenols on reactive oxygen and nitrogen species production by rat macrophages RAW 264.7. Physiol. Res. 2007 [Epub ahead of print].
27. Rahman I, Biswas SK, Kirkham PA. Regulation of inflammation and redox signaling by dietary polyphenols. Biochem. Pharmacol. 2006;72:1439-1452.
28. García-Mediavilla V, Crespo I, Collado PS, Esteller A, Sánchez-Campos S, Tunón MJ, González-Gallego J. The anti-inflammatory flavones quercetin and kaempferol cause inhibition of inducible nitric oxide synthase, cyclooxygenase-2 and reactive C-protein, and downregulation of the nuclear factor kappaB pathway in Chang liver cells. Eur. J. Pharmacol. 2007;557:221-229.
29. Li X, Stark GR. NFκB-dependent signaling pathways. Exp. Hematol. 2002;30:285-296.
30. Ishii K, Furuta T, Kasuya Y. High-performance liquid chromatographic determination of quercetin in human plasma and urine utilizing solid-phase extraction and ultraviolet detection. J. Chromatogr. 2003;794:49-56.
31. Winer J, Jung CKS, Shackel I, Williams PM. Development and validation of real-time quantitative reverse transcriptase-polymerase chain reaction for monitoring gene expression in cardiac myocytes in vitro. Anal. Biochem. 1999;270: 41-49.
32. t method. Methods 2001;25: 402-408.
33. Dill DB, Costill DL. Calculation of percentage changes in volumes of blood, plasma, and red cells in dehydration. J. Appl. Physiol. 1974;37:247-248.
34. Smith LL, Brunetz MH, Chenier TC, McCammon MR, Houmard JA, Franklin ME, Israel RG. The effects of static and ballistic stretching on delayed onset muscle soreness and creatine kinase. Res. Q. Exerc. Sports 1993;64:103-107.
35. Nieman DC, Henson DA, Gross SJ, Jenkins DP, Davis JM, Murphy EA, Carmichael MD, Dumke CL, Utter AC, McAnulty SR, McAnulty LS, Mayer EP. Quercetin reduces illness but not immune perturbations after intensive exercise. Med. Sci. Sports Exerc. 2007;39:1561-1569.
36. Mastaloudis A, Traver MG, Carstensen K, Widrick JJ. Antioxidants did not prevent muscle damage in response to an ultramarathon run. Med. Sci. Sports Exerc. 2006;38:72-80.
37. MacRae HSH, Mefferd DM. Dietary antioxidant supplementation combined with quercetin improves cycling time trial performance. Int. J. Sport Nutr. Exerc. Metab. 2006;16:405-419.
38. Dimova S, Mugabowindekwe R, Willems T, Brewster ME, Noppe M, Ludwig A, Jorissen M, Augustijns P. Safety-assessment of 3-methoxyquercetin as an antirhinoviral compound for nasal application: effect on ciliary beat frequency. Int. J. Pharm. 2003;263:95-103.